Novartis Archives - Pharmaphorum

Novartis pays up to $1 billion for potential eczema drug

https://pharmaphorum.com/news/novartis-increases-its-immunology-footprint-with-1-billion-deal/

Novartis to cease antibiotic R&D despite superbug threat

https://pharmaphorum.com/news/novartis-will-cease-reasearch-development-into-antibiotics-layoff-140-employees/

Pharma takes leading role in NHS 70th anniversary celebrations

https://pharmaphorum.com/news/pharma-takes-leading-role-in-nhs-70th-anniversary-celebrations/

CAR-Ts close to EU approval, face further US price scrutiny

https://pharmaphorum.com/news/car-t-eu-approval-face-further-us-price-scrutiny/

Lilly joins CGRP race to cure migraine

https://pharmaphorum.com/news/lilly-joins-cgrp-race-to-cure-migraine/

PTC shares soar after SMA drug data impresses market

https://pharmaphorum.com/news/ptc-therapeutics-posts-solid-sma-data/

Novartis ranked top for corporate reputation in dermatology

https://pharmaphorum.com/news/novartis-corporate-reputation-dermatology/

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Top pharmaceutical companies in the world in 2017

https://pharmaphorum.com/views-and-analysis/top-pharmaceutical-companies-world-2017/

Search